ResearchCenter for Education, Research and Advocacy
The Center for Education, Research and Advocacy conducts cutting edge clinical research studies and behavioral interventions that address LGBTQ community priorities. Our research studies help test the safety and efficacy of new medications and devices as well as implementation of new interventions. ERA studies focus on topics such as new HIV/AIDS prevention interventions, chronic disease management, behavioral health interventions, patient engagement, cancer and care coordination.
Howard Brown is committed to community-informed research which recognizes researchers, community-based organizations and community members as important contributors to the research process. We are committed to research that respects the rights of participants, addresses community needs and uses study data to address health disparities and improve health outcomes for the LGBTQ community.
Our clinical trials advance biomedical treatments and technologies that work for LGBTQ people as well as offer expanded access treatments to patients who need them. ERA participates in drug and device trials, ranging from Phase II-IV, focusing on Infectious Diseases. This scope includes treatment naïve & treatment experienced (HIV/AIDS), intervention (PrEP) and sexually transmitted infections.
The ERA research team has participated in trials that are vital to the HIV impacted population, helping to bring highly effective and safer treatment options to our community, as well as new medications for salvage therapy. In addition, we participate in HIV treatment simplification trials to identify better strategies to care for people living with HIV. Howard Brown’s research team includes three clinical research coordinators & one research assistant to support our ongoing clinical trials.
ERA’s behavioral studies range from randomized control trials to testing the adoption of evidence-based practice in real world settings. Our research plays an important role in better understanding how patients access primary care as well as hinders patient retention and treatment implementation. ERA participates in an array of behavioral studies focusing on patient linkage and retention in HIV care and treatment, Pre-Exposure Prophylaxis (PrEP) implementation, social media outreach and engagement in primary care, support for patients with cancer diagnoses, and vaccination completion.